Similar articles

• Identification of the Lipodepsipeptide MDN-0066, a Novel Inhibitor of VHL/HIF Pathway Produced by a New Pseudomonas Species.

  Cautain B, de Pedro N, Schulz C, Pascual J, Sousa Tda S, Martin J, Pérez-Victoria I, Asensio F, González I, Bills GF, Reyes F, Genilloud O, Vicente F. Cautain B, et al. PLoS One. 2015 May 27;10(5):e0125221. doi: 10.1371/journal.pone.0125221. eCollection 2015. PLoS One. 2015. PMID: 26018559 Free PMC article.
• Allelic Deletion of VHL Gene Detected in Papillary Tumors of the Broad Ligament, Epididymis, and Retroperitoneum in von Hippel-Lindau Disease Patients.

  Shen T, Zhuang Z, Gersell DJ, Tavassoli FA. Shen T, et al. Int J Surg Pathol. 2000 Jul;8(3):207-212. doi: 10.1177/106689690000800308. Int J Surg Pathol. 2000. PMID: 11493991
• Frequent Mutations of VHL Gene and the Clinical Phenotypes in the Largest Chinese Cohort With Von Hippel-Lindau Disease.

  Hong B, Ma K, Zhou J, Zhang J, Wang J, Liu S, Zhang Z, Cai L, Zhang N, Gong K. Hong B, et al. Front Genet. 2019 Sep 18;10:867. doi: 10.3389/fgene.2019.00867. eCollection 2019. Front Genet. 2019. PMID: 31620170 Free PMC article.
• Molecular genetic aspects of Von Hippel-Lindau (VHL) disease and criteria for DNA analysis in subjects at risk.

  Hes FJ, Lips CJ, van der Luijt RB. Hes FJ, et al. Neth J Med. 2001 Nov;59(5):235-43. doi: 10.1016/s0300-2977(01)00164-4. Neth J Med. 2001. PMID: 11705643 Review.
• Neurofibromatosis type 2 and von Hippel-Lindau disease: from gene cloning to function.

  Kley N, Whaley J, Seizinger BR. Kley N, et al. Glia. 1995 Nov;15(3):297-307. doi: 10.1002/glia.440150310. Glia. 1995. PMID: 8586465 Review.